Amone these product, Roxithormycin has got COS certificate, while Nystatin, Azithromycin and Netilmicin Sulfate are under the FDA or COS cortification.
Food and Drug Administration (FDA) has issued a second approvable letter for bazedoxifene, a selective estrogen receptor modulator, for the prevention of postmenopausal osteoporosis.
After reiewing the issues raised in the petition, FDA determined that its standards for approal of the generic drug application for bupropion are appropriate.
Approved by the FDA in 2001, the patch is sold by prescription and releases ethinyl estradiol (a type of estrogen), and a progestin called norelgestromin via the skin into the bloodstream.